Baron Asset Fund rose 18.98% in Q2 2026, outperforming its benchmark driven by strong stock selection in SpaceX. Read the ...
Baron Asset Fund initiated a position in Edwards Lifesciences due to its dominant heart valve market share. Read the full analysis for more details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results